Investor Relations

Announcements and Others

Date Year  
2019.11.19 UNUSUAL PRICE AND TRADING VOLUME MOVEMENTS
2019.11.15 COMPANY INFORMATION SHEET
2019.11.15 LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
2019.11.15 CHANGE OF NON-EXECUTIVE DIRECTOR
2019.11.11 THIRD QUARTERLY RESULTS ANNOUNCEMENT FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2019
2019.11.06 MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2019
2019.11.03 CHANGE OF CHIEF FINANCIAL OFFICER
2019.10.25 NOTICE OF BOARD MEETING
2019.10.21 COMPANY INFORMATION SHEET
2019.10.21 LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
2019.10.21 (1) CHANGE OF CHAIRMAN AND RE-DESIGNATION OF DIRECTOR (2) APPOINTMENT OF EXECUTIVE DIRECTOR AND (3) CHANGE OF AUTHORISED REPRESENTATIVE AND COMPLIANCE OFFICER
2019.10.15 Company Information Sheet
2019.10.15 List of Directors and their Role and Function
2019.10.15 Appointment of Independent Non-executive Director
2019.10.10 Company Information Sheet
2019.10.10 List of Directors and their Role and Function
2019.10.10 Appointment of Independent Non-executive Director
2019.10.09 Supplemental Announcement to Annual Results Announcement and the Annual Report for the Year Ended 31 December 2018
2019.10.04 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2019
2019.09.13 Change of Company Secretary, Authorised Representative and Process Agent
2019.09.09 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2019
2019.08.21 Discloseable Transaction Co-operation Agreement in Relation to the Lab Assets of Biocell Technology Limited
2019.08.21 Company Information Sheet
2019.08.21 List of Directors and their Role and Function
2019.08.19 Resignation of Independent Non-executive Director
2019.08.15 Company Information Sheet
2019.08.15 List of Directors and their Role and Function
2019.08.14 Interim Results Announcement for the Six Months Ended 30 June 2019
2019.08.12 Resignation of Independent Non-executive Director and Appointment of Compliance Adviser
2019.08.02 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2019
2019.08.01 Notice of Board Meeting
2019.07.24 Company Information Sheet
2019.07.19 Announcement Completion of Training Requirements
2019.07.03 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2019
2019.07.02 List of Directors and their Role and Function
2019.07.02 Appointment of Non-executive Director
2019.06.20 Announcements and Notices - Voluntary Announcement in Relation to Profit Guarantee in Respect of the Acquisition of 70% Equity Interest in AK Business and 70% Equity Interest in Weikai Business
2019.06.18 Poll Results of the Annual General Meeting Held on 18 June 2019
2019.06.05 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2019
2019.05.30 Company Information Sheet
2019.05.29 Supplemental Announcement Regarding Annual Results Announcement and the Annual Report for the Year Ended 31 December 2018
2019.05.20 Update on Placing of New Shares under General Mandate Termination of Placing Agreement
2019.05.16 Proxy Form for the Annual General Meeting
2019.05.16 Notice of Annual General Meeting
2019.05.15 First Quarterly Results Announcement for the Three Months Ended 31 March 2019
2019.05.15 (1) Poll Results of the Extraordinary General Meeting Held on 15 May 2019; (2) Share Consolidation and (3) Adjustments to Outstanding Share Options
2019.05.06 Supplemental Announcement
2019.05.02 Notice of Board Meeting
2019.05.02 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2019
2019.04.26 Placing of New Shares under General Mandate
2019.04.25 Proxy Form for the Extraordinary General Meeting
2019.04.25 Notice of Extraordinary General Meeting
2019.04.24 Update on Despatch of the Circular and Revised Expected Timetable in Relation to Proposed Share Consolidation
2019.04.12 Exchange Notice - Resumption of Trading  
2019.04.12 Annual Results for the Year Ended 31 December 2018 and Resumption of Trading
2019.04.03 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2019
2019.04.01 Exchange Notice - Suspension of Trading  
2019.04.01 Suspension of Trading of Shares
2019.03.29 Notice of Board Meeting
2019.03.26 Delay in Publication of Annual Results and Despatch of Annual Report for the Year Ended 31 December 2018, PostpOnement of Board Meeting, Suspension of Trading, and Delay in Despatch for Circular of Share Consolidation
2019.03.15 Proposed Share Consolidation
2019.03.15 Notice of Board Meeting
2019.03.11 Profit Warning
2019.03.04 Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2019
2019.02.01 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2019
2019.01.04 (1) Change of Company Secretary and (2) Change of Authorised Representative
2019.01.03 Shenzhen Ainear Recognized As ''guangdong Corneal Regeneration Material Engineering Technical Research Center''
2019.01.03 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2018

IR Contact

China Regenerative Medicine International Limited

A:

Rooms 3006–10, 30/F., China Resources Building, 26 Harbour Road, Wanchai, Hong Kong

E: info@crmi.hk|

T: +852 3966 8388 |

F: +852 2802 0026